The use of recombinant tissue-type plasminogen activator for the treatment of sudden and chronic hearing loss

International Tinnitus Journal

Volumn 11, Issue 2, 2005, Pages 181-184

  Mora, Renzo ^a,b   Dellepiane, Massimo ^a   Mora, Francesco ^a   Jankowska, Barbara ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b NONE   (Italy)

Author keywords

Chronic decreasing cochlear function; Sudden hearing loss; Tissue type plasminogen activator

Indexed keywords

ALTEPLASE; FIBRINOGEN; PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUDIOMETRY; BLOOD CLOTTING; COCHLEA; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; HEARING LOSS; HEART INFARCTION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; OTOACOUSTIC EMISSION; PATIENT MONITORING; PRIORITY JOURNAL; SUDDEN DEAFNESS; TYMPANOMETRY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COCHLEA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBRINOGEN; FIBRINOLYTIC AGENTS; HEARING LOSS, SENSORINEURAL; HEARING LOSS, SUDDEN; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROTHROMBIN; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 31044451360     PISSN: 09465448     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hultcrantz E. Sudden deafness. A critical evaluation of pathogenesis and "cure." Otorhinolaryngol Nova 9:178-189, 1999.
2. Cruickshanks KJ, Wiley TL, Tweed TS, et al. Prevalence of hearing loss in older adults in Beaver Dam, Wisconsin: The Epidemiology of Hearing Loss Study. Am J Epidemiol 148:879-886, 1998.
3. Mulrow CD, Aguilar C, Endicott JE, et al. Association between hearing impairment and the quality of life of elderly individuals. Am Geriatr Soc 38:45-50, 1990.
4. Veldman J. Immuno-mediated sensorineural hearing loss. Auris Nasus Larynx 25:109-131, 1998.
5. Walch C, Anderhuber W, Walzl M. H.E.L.P. therapy in sudden deafness. Laryngorhinootologie 75:641-645, 1996.
6. Kubo T, Matsunaga T, Asai H, et al. Efficacy of defibrinogenation and steroid therapies on sudden deafness. Arch Otolaryngol Head Neck Surg 114:649-652, 1998.
7. Hagen R. Fibrinolytic therapy in sudden deafness with recombinant tissue-type plasminogen activator. Hemorrhagic and therapeutic effects. Laryngorhinootologie 70:353-358, 1991.
8. Lagares A, Gomez PA, Loboto RD, et al. Cerebral aneurysm rupture after r-TPA thrombolysis for acute myocardial infarction. Surg Neurol 52:623-626, 1999.
9. Sloan MA, Price TR, Petito CK, et al. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: The Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience. Neurology 45:649-658, 1995.
10. Baujat B, De Minteguiaga C, Lecanu JB, et al. Is sudden sensorineural hearing loss a therapeutic emergency? Early results in a prospective cohort of 136 patients. Ann Otolaryngol Chir Cervicofac 119:3-11, 2002.
11. Ziegler EA, Hohlweg-Majert B, Maurer J, Mann WJ. Epidemiological data of patients with sudden hearing loss: A retrospective study over a period of three years. Laryngorhinootologie 82:4-8, 2003.
12. Berrocal JR, Ramirez-Camacho R. Sudden sensorineural hearing loss: Supporting the immunologic theory. Ann Otol Rhinol Laryngol 111:989-997, 2002.
13. Tran Ba Huy P. Idiopathic sudden sensorineural hearing loss. Reasons for defeat, conditions for victory. Otorhinolaryngology 9:171-177, 1999.
14. Lefebvre PP, Staecker H. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: A pilot study. Acta Otolaryngol 122:698-702, 2002.
15. Kitajiri S, Tabuchi K, Hiraumi H, Hirose T. Is corticosteroid therapy effective for sudden-onset sensorineural hearing loss at lower frequencies? Arch Otolaryngol Head Neck Surg 128:365-367, 2002.
16. Miller J, Dengerink H. Control of inner ear blood flow. Am J Otolaryngol 9:302-316, 1988.
17. Gatehouse S, Lowe G. Whole blood viscosity and red cell filterability as factors in sensorineural hearing impairment in the elderly. Arch Otolaryngol Head Neck Surg 476:37-43, 1991.
18. Anderson T, Meredith I, Yeung A, et al. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 332:488-493, 1995.
19. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587, 1995.
20. Carlson MD, Leber S, Deveikis J, Silverstein FS. Successful use of rt-PA in pediatric stroke. Neurology 57:157-158, 2001.
21. Ganti AK, Potti A, Yegnanarayan R. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 levels in acute myocardial infarction. Pathophysiol Haemostat Thromb 32:80-84, 2002. 185-188